Does BENRALIZUMAB Cause Injection site erythema? 54 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 54 reports of Injection site erythema have been filed in association with BENRALIZUMAB (FASENRA). This represents 0.3% of all adverse event reports for BENRALIZUMAB.
54
Reports of Injection site erythema with BENRALIZUMAB
0.3%
of all BENRALIZUMAB reports
0
Deaths
5
Hospitalizations
How Dangerous Is Injection site erythema From BENRALIZUMAB?
Of the 54 reports, 5 (9.3%) required hospitalization.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BENRALIZUMAB. However, 54 reports have been filed with the FAERS database.
What Other Side Effects Does BENRALIZUMAB Cause?
Asthma (2,457)
Dyspnoea (1,604)
Death (1,336)
Drug ineffective (1,266)
Cough (793)
Headache (788)
Product dose omission issue (713)
Pneumonia (710)
Wheezing (619)
Malaise (514)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which BENRALIZUMAB Alternatives Have Lower Injection site erythema Risk?
BENRALIZUMAB vs BENSERAZIDE
BENRALIZUMAB vs BENSERAZIDE\LEVODOPA
BENRALIZUMAB vs BENZALKONIUM
BENRALIZUMAB vs BENZOCAINE
BENRALIZUMAB vs BENZODIAZEPINE